The research findings
The research team from Cardiff University found direct evidence that those who took the anti-inflammatory drug survived from cancer for longer.
They also identified the key mechanisms, including reduction in cancer-related inflammation and abnormal clotting, that could explain the effect.
In fact, a number of studies in the review, suggested that aspirin could boost cancer survival chances by about 20 percent.
However, the team also stressed that further evidence is currently needed as the results varied greatly between the trials.
source: express.co.uk